| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 2 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | United States | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Australia | 1 | |
| #6 | Brazil | 1 | |
| #7 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Larsson Joakim | 10 |
| #2 | Dreisch Klaus | 10 |
| #3 | Brimert Thomas | 6 |
| #4 | Evenas Johan | 5 |
| #5 | Evenäs Johan | 5 |
| #6 | Rutzler Michael | 3 |
| #7 | Rützler Michael | 3 |
| #8 | Joakim Larsson | 1 |
| #9 | Klaus Dreisch | 1 |
| #10 | Johan Evenäs | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017186893A1 | Compounds for modulating aquaporins | |
| BR112017008594A2 | 2- (1,2,4-triazol-3-ylsulfanyl) -n-1,3,4-thiadiazol-2-yl acetamide derivatives that are useful for the treatment of diabetes inter alia |